Trials / Recruiting
RecruitingNCT07365553
Omega-3, Autism Spectrum Disorder (ASD)
Omega-3 Fatty Acids and Autism Spectrum Disorder (ASD) - A Double-blind Randomized Controlled Trial of Omega-3 Fatty Acids in Youth With ASD
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).
Detailed description
This is a 12 week study to investigate the effects of omega-3 PUFAs in children (6-17 years-old) with ASD. The primary outcome will be the clinical symptoms rated by the Aberrant Behavior Checklist (ABC). The secondary outcomes will be inflammatory biomarkers, cognitive function and physiological markers such as heart-rate variability (HRV).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 | Omega-3 PUFAs |
| DIETARY_SUPPLEMENT | Placebo | Soybean Oil |
Timeline
- Start date
- 2022-07-15
- Primary completion
- 2026-06-30
- Completion
- 2026-07-31
- First posted
- 2026-01-26
- Last updated
- 2026-01-26
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07365553. Inclusion in this directory is not an endorsement.